Who
Matthew McManus
President - Diag & Spatial Bio
Company insider
Files Form 4 as: President - Diag & Spatial Bio, Bio-Techne; EVP & Chief Operating Officer, Azenta.
In numbers
- Trades disclosed
- 24
- Buys
- 1
- Sells
- 0
- Bought
- $502K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 19 Aug 2022
- Last trade
- 1 Feb 2026
- Last filed
- 3 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Feb 2026filed 3 Feb 2026 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code M | —4,621 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code F | $107K1,665 at $64.09 | filing |
| 1 Feb 2026filed 3 Feb 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —4,621 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —4,621 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code M | —4,621 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code F | $107K1,665 at $64.09 | filing |
| 15 Aug 2025filed 19 Aug 2025 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —2,637 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —19,243 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —9,622 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —24,614 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code M | —2,637 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code F | $47K880 at $53.60 | filing |
| 1 Feb 2025filed 4 Feb 2025 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code M | —4,620 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code M | —4,620 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | TECH Bio-TechneLife-science tools | SEC FORM 4 Code F | $121K1,642 at $73.55 | filing |
| 15 Aug 2024filed 3 Feb 2025 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —15,825 at $0.00 | filing |
| 15 Aug 2024filed 19 Aug 2024 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —15,818 at $0.00 | filing |
| 15 Aug 2024filed 19 Aug 2024 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,912 at $0.00 | filing |
| 15 Aug 2024filed 19 Aug 2024 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —21,320 at $0.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | TECH Bio-Techneoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,888 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.